Clin Mol Hepatol.
2023 Oct;29(4):1048-1049. 10.3350/cmh.2023.0261.
Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
- Affiliations
-
- 1Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea
- 2Department of Internal Medicine, Seoul University Bundang Hospital, Seongnam, Korea
- 3Center for Artificial Intelligence in Healthcare, Seoul University Bundang Hospital, Seongnam, Korea
- 4Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2546392
- DOI: http://doi.org/10.3350/cmh.2023.0261
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Evidence-based hyponatremia management in liver disease
- Letter regarding “Evidence-based hyponatremia management in liver disease”
- Erratum to ‘Correspondence on Letter regarding “Evidencebased hyponatremia management in liver disease”’ [Clin Mol Hepatol 2023;29:1048-1049]
- Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
- LETter To the EditoR Standards (LETTERS): Considerations for Authors, Reviewers, and Editors
